Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 β-lactamase: Defining a unique family of class C enzymes

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 7, 2005, Pages 2941-2948

  Hujer, Kristine M ^a   Hamza, Nashaat S ^b   Hujer, Andrea M ^a   Perez, Federico ^a   Helfand, Marion S ^a   Bethel, Christopher R ^a   Thomson, Jodi M ^a   Anderson, Vernon E ^a   Barlow, Miriam ^c   Rice, Louis B ^a   Tenover, Fred C ^d   Bonomo, Robert A ^a,e  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c EMORY UNIVERSITY   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^e LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADC 7 BETA LACTAMASE; AMPICILLIN; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE AMPC; CEFALORIDINE; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORINASE; CILASTATIN PLUS IMIPENEM; CLAVULANIC ACID; ENZYME VARIANT; ERTAPENEM; IMIPENEM; MEROPENEM; NITROCEFIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; SULOPENEM; SULTAMICILLIN; TAZOBACTAM; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ALLELE; AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIUM; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME KINETICS; ESCHERICHIA COLI; ESCHERICHIA COLI DH10B; GENE AMPLIFICATION; GENE EXPRESSION; ISOELECTRIC FOCUSING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGELLA URETHRALIS; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FAMILY; UNITED STATES;

ACINETOBACTER BAUMANNII; ALLELES; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; BETA-LACTAMASES; BETA-LACTAMS; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINASE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS);

EID: 21444461393     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.7.2941-2948.2005     Document Type: Article

References (48)

1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
2. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
3. Beadle, B. M., and B. K. Shoichet. 2002. Structural basis for imipenem inhibition of class C β-lactamases. Antimicrob. Agents Chemother. 46:3978-3980.
4. Beceiro, A., L. Dominguez, A. Ribera, J. Vila, F. Molina, R. Villanueva, J. M. Eiros, and G. Bou. 2004. Molecular characterization of the gene encoding a new AmpC β-lactamase in a clinical strain of Acinetobacter genomic species 3. Antimicrob. Agents Chemother. 48:1374-1378.
5. Bonomo, R. A., J. Liu, Y. Chen, L. Ng, A. M. Hujer, and V. E. Anderson. 2001. Inactivation of CMY-2 β-lactamase by tazobactam: initial mass spectroscopic characterization. Biochim. Biophys. Acta 1547:196-205.
6. Bou, G., G. Cervero, M. A. Dominguez, C. Quereda, and J. Martinez-Beltran. 2000. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases. J. Clin. Microbiol. 38:3299-3305.
7. Bou, G., and J. Martinez-Beltran. 2000. Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 44:428-432.
8. Bulychev, A., and S. Mobashery. 1999. Class C β-lactamases operate at the diffusion limit for turnover of their preferred cephalosporin substrates. Antimicrob. Agents Chemother. 43:1743-1746.
9. Bush, K., C. Macalintal, B. A. Rasmussen, V. J. Lee, and Y. Yang. 1993. Kinetic interactions of tazobactam with β-lactamases from all major structural classes. Antimicrob. Agents Chemother. 37:851-858.
10. Cisneros, J. M., and J. Rodriguez-Bano. 2002. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin. Microbiol. Infect. 8:687-693.
11. Clark, N. M., J. Patterson, and J. P. Lynch III. 2003. Antimicrobial resistance among gram-negative organisms in the intensive care unit. Curr. Opin. Crit. Care 9:413-423.
12. Corbella, X., J. Ariza, C. Ardanuy, M. Vuelta, F. Tubau, M. Sora, M. Pujol, and F. Gudiol. 1998. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J. Antimicrob. Chemother. 42:793-802.
13. Giamarellos-Bourboulis, E. J., E. Xirouchaki, and H. Giamarellou. 2001. Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii. Diagn. Microbiol. Infect. Dis. 40:117-120.
14. Gomez, J., E. Simarro, V. Banos, L. Requena, J. Ruiz, F. Garcia, M. Canteras, and M. Valdes. 1999. Six-year prospective study of risk and prognostic factors in patients with nosocomial sepsis caused by Acinetobacter baumannii. Eur. J. Clin. Microbiol. Infect. Dis. 18:358-361.
15. Gootz, T., J. Retsema, A. Girard, E. Hamanaka, M. Anderson, and S. Sokolowski. 1989. In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents. Antimicrob. Agents Chemother. 33:1160-1166.
16. Hall, B. G. 2001. CodonAlign, 1.0 ed. [Online.] http://homepage.mac.com/ barryghall/Software.html.
17. Hamilton-Miller, J. M. 2003. Chemical and microbiologie aspects of penems, a distinct class of β-lactams: focus on faropenem. Pharmacotherapy 23:1497-1507.
18. Huelsenbeck, J. P., and F. Ronquist. 2001. MrBayes: Bayesian inference of phylogeny. Bioinformatics 17:754-755.
19. Hujer, A. M., C. R. Bethel, and R. A. Bonomo. 2004. Antibody mapping of the linear epitopes of CMY-2 and SHV-1 β-lactamases. Antimicrob. Agents Chemother. 48:3980-3988.
20. Hujer, A. M., K. M. Hujer, and R. A. Bonomo. 2001. Mutagenesis of amino acid residues in the SHV-1 β-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance. Biochim. Biophys. Acta 1547:37-50.
21. Hujer, A. M., M. G. Page, M. S. Helfand, B. Yeiser, and R. A. Bonomo. 2002. Development of a sensitive and specific enzyme-linked immunosorbent assay for detecting and quantifying CMY-2 and SHV β-lactamases. J. Clin. Microbiol. 40:1947-1957.
22. Levin, A. S. 2003. Treatment of Acinetobacter spp. infections. Expert Opin. Pharmacother. 4:1289-1296.
23. Levin, A. S., C. E. Levy, A. E. Manrique, E. A. Medeiros, and S. F. Costa. 2003. Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int. J. Antimicrob. Agents 21:58-62.
24. Mammeri, H., L. Poirel, N. Mangeney, and P. Nordmann. 2003. Chromosomal integration of a cephalosporinase gene from Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to β-lactams. Antimicrob. Agents Chemother. 47:1536-1542.
25. Mau, B., and M. Newton. 1997. Phylogenetic inference for binary data on dendrograms using Markov chain Monte Carlo. J. Comput. Graph. Stat. 6:122-131.
26. Mau, B., M. A. Newton, and B. Larget. 1999. Bayesian phylogenetic inference via Markov chain Monte Carlo methods. Biometrics 55:1-12.
27. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
28. Navia, M. M., J. Ruiz, and J. Vila. 2002. Characterization of an integron carrying a new class D β-lactamase (OXA-37) in Acinetobacter baumannii. Microb. Drug Resist. 8:261-265.
29. Paterson, D. L., L. B. Rice, and R. A. Bonomo. 2001. Rapid method of extraction and analysis of extended-spectrum β-lactamases from clinical strains of Klebsiella pneumoniae. Clin. Microbiol. Infect. 7:709-711.
30. Perilli, M., A. Felici, A. Oratore, G. Cornaglia, G. Bonfiglio, G. M. Rossolini, and G. Amicosante. 1996. Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates. Antimicrob. Agents Chemother. 40:715-719.
31. Poirel, L., A. Karim, A. Mercat, I. Le Thomas, H. Vahaboglu, C. Richard, and P. Nordmann. 1999. Extended-spectrum β-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. J. Antimicrob. Chemother. 43:157-158.
32. Poirel, L., O. Menuteau, N. Agoli, C. Cattoen, and P. Nordmann. 2003. Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J. Clin. Microbiol. 41:3542-3547.
33. Rahal, J. J., C. Urban, and S. Segal-Maurer. 2002. Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites. Clin. Infect. Dis. 34:499-503.
34. Rannala, B., and Z. Yang. 1996. Probability distribution of molecular evolutionary trees: a new method of phylogenetic inference. J. Mol. Evol. 43:304-311.
35. Sanders, C. C., and W. E. Sanders, Jr. 1979. Emergence of resistance to cefamandole: possible role of cefoxitin-inducible β-lactamases. Antimicrob. Agents Chemother. 15:792-797.
36. Sato, K., and T. Nakae. 1991. Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance. J. Antimicrob. Chemother. 28:35-45.
37. Scerpella, E. G., A. R. Wanger, L. Armitige, P. Anderlini, and C. D. Ericsson. 1995. Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: results of the case-control and molecular epidemiologic investigations. Infect. Control Hosp. Epidemiol. 16:92-97.
38. Segal, H., E. C. Nelson, and B. Gay Elisha. 2004. Genetic environment and transcription of ampC in an Acinetobacter baumannii clinical isolate. Antimicrob. Agents Chemother. 48:612-614.
39. Segal, H., R. Thomas, and B. Gay Elisha. 2003. Characterization of class 1 integron resistance gene cassettes and the identification of a novel IS-like element in Acinetobacter baumannii. Plasmid 49:169-178.
40. Seifert, H., A. Strate, and G. Pulverer. 1995. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 74:340-349.
41. Smolyakov, R., A. Borer, K. Riesenberg, F. Schlaeffer, M. Alkan, A. Porath, D. Rimar, Y. Almog, and J. Gilad. 2003. Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J. Hosp. Infect. 54:32-38.
42. Sun, G., M. T. Kinter, and V. E. Anderson. 2003. Mass spectrometric characterization of mitochondrial electron transport complexes: subunits of the rat heart ubiquinol-cytochrome c reductase. J. Mass Spectrom. 38:531-539.
43. Swofford, D. L. 2000. PAUP*. Phylogenetic analysis using parsimony (*and other methods). 4.0b4a ed. Sinauer Associates, Sunderland, Mass.
44. Tavaré, L. 1986. Some probabilistic and statistical problems on the analysis of DNA sequences. Lect. Math. Life Sci. 17:57-86.
45. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:4876-4882.
46. Urban, C., S. Segal-Maurer, and J. J. Rahal. 2003. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin. Infect. Dis. 36:1268-1274.
47. Yong, D., J. H. Shin, S. Kim, Y. Lim, J. H. Yum, K. Lee, Y. Chong, and A. Bauernfeind. 2003. High prevalence of PER-1 extended-spectrum β-lactamase-producing Acinetobacter spp. in Korea. Antimicrob. Agents Chemother. 47:1749-1751.
48. Yoon, J., C. Urban, C. Terzian, N. Mariano, and J. J. Rahal. 2004. In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 48:753-757.